BACKGROUND: Spontaneous coronary artery dissection (SCAD) is an uncommon idiopathic disorder predominantly affecting young, otherwise healthy women. Rare familial cases reveal a genetic predisposition to disease. The aim of this study was to identify a novel susceptibility gene for SCAD.
S
pontaneous coronary artery dissection (SCAD) is an uncommon and under-recognized cause of acute coronary syndrome affecting a young, otherwise healthy, predominantly female population that lacks traditional risk factors for atherosclerotic coronary artery disease. 1 SCAD is characterized by disruption of the coronary artery wall by 2 proposed mechanisms: a tear between the intimal and medial layers, creating an intimal flap, or within the medial layer in conjunction with an intramural hematoma. Both types can result in the blockage of the vessel lumen and impaired blood flow, precipitating ischemia and myocardial infarction. There is currently limited understanding of treatments to prevent SCAD from occurring. Indeed, the pathogenesis of SCAD, potentially caused by both environmental triggers and genetic susceptibility, is poorly understood. The 29% 10-year recurrence rate 2 and common association with fibromuscular dysplasia suggests that SCAD is a clinical manifestation of a chronic, systemic arteriopathy. 1 SCAD is a sporadic disorder in a majority of individuals. However, reports of rare familial associations, comprised of ≥2 family members affected by SCAD, [3] [4] [5] implicate a genetic predisposition to disease. Sporadic SCAD could also have genetic underpinnings due to de novo, recessive, or dominant variants with incomplete penetrance. Here, we used next-generation sequencing and targeted mutation scanning in a familial case and large sporadic SCAD cohort to identify TLN1, encoding the cytoskeletal protein talin 1, as a novel susceptibility gene for familial and sporadic SCAD.
METHODS
The data that support the findings of this study are available from the corresponding author on reasonable request. Written informed consent was obtained from all participating subjects under a research protocol approved by the Mayo Clinic Institutional Review Board. The methods of this study are detailed in the Data Supplement.
RESULTS

Whole-Exome Sequencing Uncovers TLN1 as a Novel Disease-Associated Gene in Familial SCAD
Clinical data and DNA samples were obtained from 5 individuals of a 2-generation family, comprised of 3 individuals with angiographically confirmed SCAD (SCAD-01; Figure 1A ; Table 1 ). The male proband (III.1), his female sibling (III.2), and their maternal aunt (II.3) developed SCAD in their 40s. Different coronary arteries were affected among the 3 family members. Physical findings of a connective tissue disorder were absent in both siblings, who underwent medical genetics evaluation. The female sibling's phenotype was notable for concomitant coronary artery tortuosity, 6 fibromuscular dysplasia of renal and iliac arteries, and recurrent SCAD in a different coronary artery 2 years after the initial event. The mother of the affected siblings (II.2), at 74 years of age, had not had a SCAD event or vascular imaging. By history, the maternal grandfather (I.1) had a fatal myocardial infarction at the age of 64 years, but no information is available about his cardiovascular risk factors or whether he had coronary artery imaging. To identify a genetic basis for SCAD in this family, we hypothesized autosomal dominant inheritance of a heterozygous mutation with incomplete penetrance.
Whole-exome sequencing (WES) was performed on DNA samples from 5 living relatives in SCAD-01. Exome coverage was similar for each sample with, on average, over 25× coverage in 80% of the coding and untranslated regions. Variant call format files were binned and analyzed for each individual with IVA software. Among the 5 family members, over 2 million variants in 24 000 genes were identified. To uncover rare, segregating, predicted-damaging variants, an iterative filtering approach was used that revealed TLN1, encoding the cytoskeletal protein talin 1, as the top candidate gene ( Figure 1B ). The identified heterozygous nucleotide transition in TLN1 (NM_006289.3:c.6037G>A) was verified by Sanger sequencing ( Figure 1C ) and resulted in a protein substitution (p.A2013T) within a highly conserved region of a β-integrin-binding domain ( Figure 1D ). The variant is rare in the general population, with a minor allele frequency of 0.053% in Genome Aggregation Database and predicted to be deleterious. Combined annotation-dependent depletion-a framework that integrates 63 distinct annotations to measure the deleteriousness of the variant-assigned the variant a score of 34, placing it in the 99th percentile for missense combined annotation-dependent depletion scores. At a gene level, TLN1 is intolerant to variation, with high probability of loss-of-function intolerance (pLI=1) and missense variant intolerance (Z score=5.13). Moreover, it is highly expressed in arterial tissues.
To ensure a plausible pathogenic variant was not missed by WES because of incomplete exon coverage or location in an uncovered regulatory region, wholegenome sequencing (WGS) was performed using samples from the proband (III.1) and the affected maternal aunt (II.3). Genome coverage was similar for both samples with, on average, 30× coverage in 96% of the genome. The same WES variant filtering scheme was applied with the ability to now include transcription factor-binding sites, enhancer regions, and microRNA coding/binding sites ( Figure IA and IB in the Data Supplement). Taking regulatory regions into account, TLN1 remained the top candidate gene. The 2 other genes with segregating missense and promoter variants, CUL9 and XRCC5, respectively, are not highly or differentially expressed in arterial tissues and have nonvascular gene deletion phenotypes in mice (Table I in the Data Supplement).
To verify that our predicted-damaging variant, gene level, and arterial tissue expression filters did not elimi-nate a plausible candidate gene among the 212 segregating coding variants ( Figure 1B ) and 76 regulatory variants ( Figure I in the Data Supplement), we further scrutinized these genes for biological associations with connective tissue disorders and aortopathies. For this purpose, a biological context filter comprised of 27 aortopathy genes (Invitae, San Francisco, CA) and 57 connective tissue disorder genes (GeneDx, Gaithersburg, MD) was utilized. This comprehensive analysis did not reveal additional segregating variants in these human disease genes.
Talin 1 Is Robustly Expressed in Coronary Arteries
According to the Genotype-Tissue Expression Database, TLN1 is highly expressed in the vasculature, including the aorta, tibial, and coronary arteries. 7 Among 53 distinct tissue types, these 3 tissues were ranked in the top 5 for TLN1 gene expression. To evaluate protein expression and localization within the coronary artery, tissue sections of formalin-fixed and paraffin-embedded samples obtained from an individual without SCAD were stained with a talin 1 antibody. Congruent with our mRNA expression patterns, immunohistochemical staining for the talin 1 protein was robust, showing strong, specific staining in endothelial cells of the tunica intima and smooth muscle cells of the tunica media ( Figure 2 ). Within each layer, talin 1 was localized to the cytoplasm.
Targeted Screening Identifies Additional Rare TLN1 Variants in SCAD Cohort
Talin 1 is a 270-kDa cytoplasmic adapter protein comprised of 2541 amino acids and encompasses β-integrin- binding, F-actin-binding, and vinculin-binding domains ( Figure 3A) . 8, 9 After identification of a rare missense variant within a highly conserved β-integrin-binding domain of TLN1 in familial SCAD, we determined the prevalence and spectrum of rare TLN1 variants within binding domains in a large sporadic SCAD cohort comprised of 675 individuals.
Variants within TLN1 were first identified in a sample of 56 sporadic SCAD individuals who had previously undergone WES (n=35) or WGS (n=21). On average, over 30× coverage in 94% to 95% of TLN1-coding regions was achieved. WES and WGS variant call format files were binned separately for each individual and uploaded into IVA for subsequent analysis. Filtering for rare (<0.1%) protein-altering variants in TLN1 identified 3 heterozygous missense variants in 4 sporadic cases ( Figure 3B ; Table 1 ). These variants occurred within essential binding domains of TLN1 and were verified by Sanger sequencing ( Figure 4A ). In addition, WES and WGS from the SCAD-01 family and 56 unrelated individuals with sporadic SCAD were analyzed for copy number variation within TLN1, but no duplications or deletions were identified.
Targeted denaturing high-performance liquid chromatography heteroduplex mutation scanning of 24 exons (amino acids 171-402; 919-1340; 1961-2119; 2292-2541) overlapping β-integrin-binding, vinculinbinding, and F-actin-binding domains was screened in the remaining 619 DNA samples in our cohort. The scanning region covered over 42% of the protein. Six additional rare heterozygous missense variants were identified in 6 sporadic cases (Figures 3B and 4B ; Table 1 ).
In summary, 10 unique rare heterozygous missense variants in 11 individuals were identified in our familial case and sporadic SCAD cohort (Table 1) . All variants had a minor allele frequency of <0.06% and occurred within highly conserved β-integrin-binding, F-actin-binding, or vinculin-binding domains of TLN1 (Table 1 ; Figure II in the Data Supplement). Seven had combined annotation-dependent depletion scores greater than the 80th percentile for genome-wide missense variants. The effect of missense variants on talin 1 protein stability was assessed by 7 different in silico prediction programs. Eight of 10 substitutions were predicted destabilizing based on a negative free energy change (ΔΔG; Table 1; Table II in the Data Supplement). Among the 3 related and 10 unrelated individuals who carried a TLN1 variant, the average age at first SCAD event was 43±8 years, and the left anterior descending coronary artery was most fre- quently involved (9 of 16 initial or recurrent events), similar to reports in the literature. 1 The associated clinical characteristics and concurrent systemic arteriopathies observed among the 11 individuals were variable, and no clear genotype-phenotype association was evident. Sanger sequencing of parental DNA samples, available from 5 sporadic cases, was performed to determine inheritance of the identi- fied TLN1 variants. Similar to the familial case, each demonstrated incomplete penetrance as the variant was inherited from a parent who had not had a SCAD event ( Figure 4A and 4B).
Enrichment of rare TLN1 missense variants in SCAD
TLN1 is a large gene, increasing the likelihood of detecting rare missense variants. Accordingly, to verify an association between genetic perturbation of TLN1 and SCAD, comparative analyses were performed on SCAD cases and controls who underwent next-generation sequencing. An overrepresentation of rare missense variants was identified among individuals with SCAD both overall and within the subset of white subjects (8.8% versus 0.7%, P=0.0016; 8.5% versus 0.7%, P=0.0053; Table 2 ).
DISCUSSION
This study reveals TLN1 as a disease-associated gene among a small percentage of individuals with familial and sporadic SCAD. However, the true frequency of rare TLN1 variants in SCAD is unknown because a majority of individuals in our cohort underwent domain-targeted mutation scanning comprising <50% of the gene. Our familial case and 5 parent-proband trios revealed incomplete penetrance of the identified heterozygous missense variants, suggesting genetic and environmental modifiers in disease pathogenesis. Prospective follow-up will be required to determine whether TLN1 variants are associated with an increased rate of recurrent SCAD, as observed in 3 of 11 cases. Talin is a key component of focal adhesions (FA; Figure 5 ) 10 and essential for integrin activation. 11 The protein acts as a molecular clutch that links the actin A, Pedigrees of 4 unrelated individuals with sporadic spontaneous coronary artery dissection (SCAD) and chromatographic sequencing traces that verified variants identified by next-generation sequencing. Diagonal line, deceased; d, age at death; red font, age at SCAD event; ?, DNA unavailable. B, Similarly, pedigrees of 6 unrelated individuals shown with corresponding denaturing high-performance liquid chromatography heteroduplex profiles and sequencing traces that confirmed the 6 variants identified by targeted mutation scanning. CHF indicates congestive heart failure; and COPD, chronic obstructive pulmonary disease.
cytoskeleton to the extracellular matrix via integrins and mediates signaling. 10, 12 Vinculin stabilizes talin coupling with actin filament networks during mechanical force transduction. 10 Two isoforms of talin encoded by distinct genes exist in vertebrates-TLN1 and TLN2-that have distinct and overlapping functions. 13 TLN1 is expressed in all tissue types but most highly in vascular tissues 7 and exclusively in endothelial cells. 14 TLN2 is the predominant isoform in both brain and muscle tissue. 10 Simultaneous inactivation of both isoforms in mice leads to severe defects in skeletal muscle development. 15 Human umbilical vein endothelial cells express TLN1 only, and knockdown of the gene inhibits FA assembly, resulting in reduction of cell spreading and migration. 16 Inactivation of talin 1 in murine endothelial cells leads to defects in angiogenesis.
14 A vascular disease phenotype was similarly observed in f102k mutant talin 1 zebra fish with progressive luminal narrowing of the dorsal aorta and posterior cardinal vein and inability of endothelial cells to maintain cell spreading and actin filament networks in the presence of mechanical stimuli, such as muscle contraction and shear stress. 17 Alterations in TLN1 expression in smooth muscle cells have been associated with major human arterial diseases. A recent study observed that TLN1 was significantly downregulated in aortic tissue of patients with aortic dissection. 18 In contrast to human umbilical vein endothelial cells, knockdown of the gene in vascular smooth muscle cells was associated with increased proliferation and migration-a proposed mechanism contributing to weakening of the aortic wall. 18 Overall, these studies highlight the importance of talin 1 in vascular endothelial and smooth muscle cell biology and its essential role in arterial development and integrity. 25 within the head and rod regions of talin. We identified 10 TLN1 variants in 11 individuals within our experimentally targeted protein-binding site screens. These variants, identified in 1.5% of our SCAD cohort, are predicted to perturb talin 1 interaction with other cytoskeletal proteins and FA integrity, conferring susceptibility to SCAD.
There are considerable supportive data from mutagenesis and biochemical studies that demonstrate an impact of point mutations within F-actin-binding, β-integrin-binding, and vinculin-binding domains on protein-protein binding.
IBS2 Domain
Our familial SCAD case and a sporadic SCAD case had substitutions within the IBS2 region. Located near the C terminus of the talin rod (R11-R12), IBS2 is important for integrin clustering. 23 β-integrin tail-binding assays have demonstrated that high-affinity integrin binding requires both R11 and R12 domains of IBS2, 23 and a 2-amino acid point mutation (Leu-Ile/Ala-Ala) within this region disrupts β-integrin binding.
26
ABS1 Domain
A R297H substitution in ABS1 (F2-F3) was identified in 1 sporadic case. ABS1 is located at the N terminus of talin 1 and regulates actin polymerization by capping actin filaments. 27 Residues 209 to 400 within the ABS1 region exhibit salt-sensitive binding with F-actin in vitro, suggesting that an electrostatic interaction orchestrates binding. 20 Positively charged surface residues such as R297, found within the upper surface of the interdomain cleft in F2, may be involved in actin binding. 20 At physiological pH, arginine-a positively charged amino acid-is always protonated. A change to a histidine pHsensitive residue that titrates within a narrow pH range could, therefore, affect ABS1 binding during intracellular pH shifts.
ABS2 Domain
Four substitutions in 5 sporadic cases were identified in ABS2 (R4-R8). ABS2-a key regulator of talin 1-has been shown to be essential for FA stabilization and for generating traction forces that are required for cell migration. 28 Papillary collecting duct cells isolated from mice that expressed deletion or point mutations in talin ABS2 (located in R4 and R8) had significantly reduced actin binding and force transmission, 28 indicating that genetic disruption in these major binding regions can negatively impact cell integrity.
ABS3 Domain
A neutral-to-acidic V2440E amino acid substitution in ABS3 (R13-DD) was identified in 1 sporadic case. Located in the C terminus of the talin 1 rod, ABS3 is required for FA initiation and cell spreading. 28 A mutagenesis study revealed that the ABS3 is comprised of a highly conserved hydrophobic surface and that acidic amino acid substitutions Q2388D, Q2437E, K2443D, V2444D, and K2445D within the region resulted in significant reduction in F-actin binding.
21
VBS Domain
VBSs are found throughout the talin 1 rod, and 4 substitutions were found within a VBS. Structural and biochemical studies have found that VBSs, defined by 25 residue recognition sequence, 26 are cryptic and exposed only when mechanical force is present. 28 Point mutations in VBS consensus sequences of both α-helix 4 and 12 have been shown to disrupt the α-helix structure that is essential for vinculin binding. 26 SCAD has a striking predilection for women, who account for over 96% of the cases, suggesting that the female sex hormones estrogen and progesterone may underlie susceptibility to the disorder. Hormonal changes coupled with hemodynamic stress have been hypothesized as contributing factors in pregnancyassociated SCAD. 29 Pregnancy was a potential trigger of SCAD in 3 of our cases. Paradoxically, female sex is protective for common forms of cardiovascular disease, attributed to estrogen's promotion of vascular smooth muscle relaxation by NO release. 30, 31 However, estrogen has also been implicated in the enhanced release of matrix metalloproteinases, which can lead to degradation of extracellular matrix proteins and impaired structural integrity of the vessel wall. 32 In a large-scale gene expression analysis of estradiol-treated human umbilical vein endothelial cells, TLN1 was found to be upregulated, indicating that the gene is a target of estradiol stimulation. 33 This suggests that there may be a synergistic effect of damaging variants within cytoskeleton proteins and estrogen that contribute to a loss of structural support in arterial tissue. On the contrary, the proband in our familial case was a man whose age at SCAD was similar to his sister, implicating sex-independent factors in disease penetrance.
Our findings, together with published functional studies of talin 1 disruption, suggest that rare missense variants in TLN1 impair structural integrity of the coronary artery cytoskeleton. Further research is required to determine whether genetic alteration of other cyto-
